There are no peer-reviewed studies supporting any weight loss claims for GLP-1 patches
Patients often do not report suicidal ideation, consideration, or attempts to their health care providers
Whilst retatrutide is not currently available in the UK outside of clinical trials, your GP can help you understand which licensed treatments may be appropriate for your individual circumstances, taking into account your medical history, current medications, and weight management goals
These trials, expected to conclude by February 2026, will provide critical data on sustained weight loss, cardiovascular outcomes, and kidney function
Over a few weeks, your calendar view reveals patterns that help you and your provider fine-tune your approach
It can give extra support to people who dont meet the requirements for full-dose weight-loss meds